As of 2:31 PM on the 22nd, Celltrion Healthcare is trading at 144,700 KRW, up 1.19% from the previous day. This represents a 16.45% decline compared to December 22. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.
Today, foreigners have net sold 34,000 shares of Celltrion Healthcare, while institutions have net bought 15,000 shares, according to provisional data. Over the past five days, individual investors have net sold 331,194 shares, whereas foreigners and institutions have net bought 304,368 shares and 23,526 shares, respectively.


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
